Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation

Daily Values

Growth Metrics

Others

Ratios

Jefferson Capital (JCAP) Gains from Sales and Divestitures (2025)

Jefferson Capital has reported Gains from Sales and Divestitures over the past 1 years, most recently at $32616.0 for Q4 2025.

Quarterly Gains from Sales and Divestitures changed N/A to $32616.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $32616.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $32616.0 for FY2025, N/A changed from the prior year.
Gains from Sales and Divestitures was $32616.0 for Q4 2025 at Jefferson Capital, up from $24164.0 in the prior quarter.
Over five years, Gains from Sales and Divestitures peaked at $32616.0 in Q4 2025 and troughed at $24164.0 in Q3 2025.